Additional file 1 of Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort

Additional file 1. Genes and their alterations types covered by next-generation sequencing panels used in the study. The genes and their alterations covered by TruSight Oncology 500 tumor/ctDNA panel and TruSight Hereditary Cancer Panel are shown. The private genes and the common genes included in each next-generation sequencing panels used are also indicated.